Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Biology of Renal Carcinoma using a Mouse RCC model

ABSTRACT: The mouse renal cancer cell line RENCA was serially passaged in vivo using multiple implantation strategies (called Kidney, Tail and Lung) designed to replicate different aspects of primary tumour growth and metastasis. We have acquired methylomic data.

ORGANISM(S): Mus musculus

PROVIDER: GSE139338 | GEO | 2021/10/27

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Study of the molecular stability of patient-derived tumor xenograft (PDX) for human renal cell carcinoma (RCC) in nude mice during subsequent passages in mice

Project description:We established a large panel of preclinical models of human RCC directly from patients, faithfully reproducing the biological features of the original tumor. RCC tissues were collected for 8 years from 336 patients undergoing surgery, xenografted subcutaneously in nude mice, and serially passaged into new mice up to 13 passages. Tissue samples from the primary tumor and tumors grown in mice through passages were analyzed at the histology, genetic and for of them at the molecular levels for biological tissue stability. We established a large panel of 30 RCC models and 5 them of the clear cell type (clear cell renal cell carcinoma, CCC) were characterized at the mRNA expression level.

2016-06-29 | GSE83820 | GEO

Gene expression profiling of murine renal adenocarcinoma cells during recursive implantations

Project description:The process of serial implantation of a cell line in vivo is a known method to render a cell line increasingly aggressive. In this study, we leveraged this technique to generate increasingly aggressive sub-lines of RENCA, a mouse renal carcinoma cell line. We used different implantation strategies to dissect the different stages of tumor progression and metastasis. Cell-line derived RNA and DNA were used to analyze transcriptional, DNA and methylome profiles of the cell types, and to generate signatures able to predict global, disease-free and progression-free survival time in human patients.

2021-10-27 | GSE142109 | GEO

Study of the molecular stability of patient-derived tumor xenograft (PDX) for human renal cell carcinoma (RCC) in nude mice during subsequent passages in mice

2016-06-29 | E-GEOD-83820 | biostudies-arrayexpress

Longitudinal DNA methylation in serially passaged primary and modified human astrocytes

Project description:This DNA methylation dataset describes epigenomic changes in in vitro serially passaged primary and immortalized astrocytes, in the context of studies examining cellular aging patterns that are conserved in vivo and in vitro. Primary and fetal hTERT-immortalized astrocytes were grown under normoxic conditions and serially passaged. Longitudinal DNA samples were collected throughout passaging and DNA methylation was measured using the Infinium HumanMethylation850 BeadChip.

2023-07-21 | GSE226079 | GEO

BevR-IgG array in glioblastoma xenografts

Project description:Analysis of anti-angiogenic therapy resistance in xenografts of patient glioma samples serially passaged across generations of athymic nude mice

2016-06-21 | GSE81465 | GEO

0af07d16-fb68-4e74-8bb5-c6e61fc62814 - samples

Project description:WGS data of serially passaged TIC-enriched spheres of colorectal cancer

| EGAD00001006265 | EGA

a1636e60-b7eb-4697-9250-0fca39607383 - samples

Project description:WES data of serially passaged TIC-enriched spheres of colorectal cancer (CRC)

| EGAD00001006266 | EGA

Biology of Renal Carcinoma using a Mouse RCC model

Project description:Biology of Renal Carcinoma using a Mouse RCC model

| PRJNA579344 | ENA

Nosocomial pathogens serially passaged in silver nitrate

Project description:Nosocomial pathogens serially passaged in silver nitrate (Raw sequence reads)

| PRJNA692851 | ENA

Renal carcinoma/kidney progenitor cell chimera organoid as a novel tumorigenesis gene discovery model

Project description:Three-dimensional (3D) organoids provide a new way to model various diseases, including cancer. We made use of recently developed kidney-organ-primordia tissue-engineering technologies to create novel renal organoids for cancer gene discovery. We then tested whether our novel assays can be used to examine kidney cancer development. First, we identified the transcriptomic profiles of quiescent embryonic mouse metanephric mesenchyme (MM) and of MM in which the nephrogenesis program had been induced ex vivo. The transcriptome profiles were then compared to the profiles of tumor biopsies from renal cell carcinoma (RCC) patients, and control samples from the same kidneys. Certain signature genes were identified that correlated in the developmentally induced MM and RCC, including components of the caveolar-mediated endocytosis signaling pathway. An efficient siRNA-mediated knockdown (KD) of Bnip3, Gsn, Lgals3, Pax8, Cav1, Egfr or Itgb2 gene expression was achieved in mouse RCC (Renca) cells. The live-cell imaging analysis revealed inhibition of cell migration and cell viability in the gene-KD Renca cells in comparison to Renca controls. Upon siRNA treatment, the transwell invasion capacity of Renca cells was also inhibited. Finally, we mixed the nephron progenitors with yellow fluorescent protein (YFP)-expressing Renca cells to establish chimera organoids. Strikingly, we found that the Bnip3-, Cav1- and Gsn-KD Renca-YFP+ cells as a chimera with the MM in 3D organoid rescued, in part, the RCC-mediated inhibition of the nephrogenesis program during epithelial tubules formation. Altogether, our research indicates that comparing renal ontogenesis control genes to the genes involved in kidney cancer may provide new growth-associated gene screens and that 3D RCC-MM chimera organoids can serve as a novel model with which to investigate the behavioral roles of cancer cells within the context of emergent complex tissue structures.

2017-12-05 | GSE107657 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data